q4 earnings per share $0.26.
compname reports q3 net income of $2.7 billion, a 14 percent increase from q1.
q2 profit per share $0.15.
sees new development to expand co's current business model.
qtrly patient trends were very strong in quarter.
plan to repurchase up to $20 billion of shares in 2020.
sees fy adjusted earnings per share $1.55 to $1; full-year guidance $1 to $2.55 on a constant currency basis.
qtrly international sales grew very strong but earnings were not disclosed.
reaffirms full year sales guidance of $1.75 billion to $1 billion.
q2 operating cash flow $146 million versus $185 million.
sees q3 adjusted operating income in u.s. healthcare service sector increasing.
annellation inc - looking forward, expects to reach breakeven internationally during year-end, and to achieve breakehem internationally in 2019.
qtrly consolidated net income $232 million versus $1.22 billion.
compname reports q1 international operating loss of $13 million; q1 foreign exchange loss of 1 million.
q2 sales fell 6% to $1.19 billion.
reiterating prior year guidance; revenue guidance impacted by lower than anticipated clinic acquisitions.
